Viewing Study NCT06394804

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2026-05-05 @ 10:22 AM
Study NCT ID: NCT06394804
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2024-04-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Low-Grade Serous Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Avutometinib View
None Defactinib View
None Letrozole View
None 24-014 View